SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-12-005892
Filing Date
2012-02-06
Accepted
2012-02-06 06:13:12
Documents
2
Period of Report
2012-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO FORM 8-K v301275_8ka4.htm 8-K/A 12337
2 FORM OF AMENDMENT NO. 5 TO TRANCHE A SENIOR UNSECURED CONVERTIBLE NOTES AND TRAN v301275_ex10-1.htm EX-10.1 13292
  Complete submission text file 0001144204-12-005892.txt   26872
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-53127 | Film No.: 12571924
SIC: 4731 Arrangement of Transportation of Freight & Cargo